Literature DB >> 6090140

Characterisation of size variants of type I DNA topoisomerase isolated from calf thymus.

B Schmitt, U Buhre, H P Vosberg.   

Abstract

Calf thymus DNA topoisomerase I, which belongs to the eukaryotic type I topoisomerases, is in a typical preparation purified as a set of five major polypeptides with Mr between 70000 and 100000. At least four of these proteins have binding affinity for DNA as was shown by incubating them with radioactive single-stranded DNA after separation in dodecylsulfate polyacrylamide gels and blotting onto nitrocellulose filters. That these polypeptides have DNA relaxing activity was directly demonstrated with protein extracted from single bands of dodecylsulfate/polyacrylamide gels. We consider the 100000-Mr protein to be the native enzyme. The smaller components are catalytically active fragments of the native topoisomerase most probably arising from limited proteolysis either within the nucleus or during the purification of the enzyme. In two-dimensional non-equilibrium pH-gradient electrophoresis gels the topoisomerase size variants exhibit apparent pI values between 8.1 and 8.3, with small but distinct differences between the components. The calf thymus topoisomerase I, upon binding to phage fd-DNA, protects a stretch of 15-25 nucleotides against digestion with DNase I.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090140     DOI: 10.1111/j.1432-1033.1984.tb08440.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Topoisomerase I is associated with the regulatory region of transcriptionally active SV 40 minichromosomes.

Authors:  Y S Vassetzky; V V Bakayev; A G Kalandadze; S V Razin
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

2.  IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.

Authors:  Erasmo Martínez-Cordero; Alejandro Padilla Trejo; Diana E Aguilar León
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Sequence dependent modulating effect of camptothecin on the DNA-cleaving activity of the calf thymus type I topoisomerase.

Authors:  I I Gromova; V L Buchman; R A Abagyan; A V Ulyanov; I B Bronstein
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

4.  Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I.

Authors:  H H Guldner; C Szostecki; H P Vosberg; H J Lakomek; E Penner; F A Bautz
Journal:  Chromosoma       Date:  1986       Impact factor: 4.316

5.  Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription.

Authors:  K M Rose; J Szopa; F S Han; Y C Cheng; A Richter; U Scheer
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

Review 6.  New oral chemotherapeutic agents for lung cancer.

Authors:  E M Bengtson; J R Rigas
Journal:  Drugs       Date:  1999       Impact factor: 9.546

7.  Specific cleavage of chicken alpha A-globin and human c-Ha-ras genes by two molecular forms of calf thymus topoisomerase I.

Authors:  I B Bronstein; I I Gromova; S V Razin
Journal:  Mol Cell Biochem       Date:  1991-03-13       Impact factor: 3.396

Review 8.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Heat stress induces hsc70/nuclear topoisomerase I complex formation in vivo: evidence for hsc70-mediated, ATP-independent reactivation in vitro.

Authors:  R P Ciavarra; C Goldman; K K Wen; B Tedeschi; F J Castora
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Mammalian DNA polymerase auxiliary proteins: analysis of replication factor C-catalyzed proliferating cell nuclear antigen loading onto circular double-stranded DNA.

Authors:  L M Podust; V N Podust; J M Sogo; U Hübscher
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.